A Multi-Center, Open-Label Pharmacokinetic and Safety Study for Reduction in Fever or Management of Pain in Pediatric Subjects Aged Birth to Six Months
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Ibuprofen (Primary)
- Indications Fever; Pain
- Focus Pharmacokinetics
- Sponsors Cumberland Pharmaceuticals
- 18 Jul 2017 Status changed from not yet recruiting to recruiting.
- 12 Jun 2017 Planned initiation date changed from 1 Jan 2017 to 30 Jun 2017.
- 02 Nov 2016 Planned initiation date changed from 1 Oct 2016 to 1 Jan 2017.